We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PCAN Unveils Precision Medicine Clinical Trial
News

PCAN Unveils Precision Medicine Clinical Trial

PCAN Unveils Precision Medicine Clinical Trial
News

PCAN Unveils Precision Medicine Clinical Trial

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "PCAN Unveils Precision Medicine Clinical Trial"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The Pancreatic Cancer Action Network has announced Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer. The organization also announces the 12 initial Precision Promise Clinical Trial Consortium sites selected to participate in this groundbreaking initiative.

Bringing together the field’s key stakeholders, including clinicians, researchers and diagnostic and drug developers, Precision Promise will put the patient at the center of every decision and will advance the Pancreatic Cancer Action Network’s goal to double survival by 2020. The Pancreatic Cancer Action Network has committed a minimum initial investment of $35 million over the first four years, not including drug costs, and expects to enroll thousands of patients. 

“Precision Promise will dramatically accelerate the clinical trial process to bring promising therapies to patients faster,” said Julie Fleshman, JD, MBA, president and CEO of the Pancreatic Cancer Action Network. “Precision Promise is an unprecedented opportunity for patients and is vital to move the field forward. Instead of looking for the right patient for a clinical trial, we are designing the right clinical trial for each patient.” 

Advertisement